Study: Anti-microRNA sedate essentially lessens miR-92a levels in human peripheral blood Kumar Jeetendra | August 12, 2020 A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels from the blood of healthy humans. “According to documented, promising therapeutic possible, locked nucleic acid (LNA)-based anti-miR-92a was further developed and tested in a first in human analysis,” said Stefanie Dimmeler, PhD, Goethe University, Frankfurt, Germany and coauthors. “MRG-110 caused de-repression of …
Omega-3 rich nourishments improve forecast in patients with myocardial dead tissue Kumar Jeetendra | October 27, 2020 A team of researchers from the Germans Trias I Pujol Hospital and Research Institute (IGTP) and the Hospital del Mar Medical Research Institute (IMIM) has shown that regularly consuming foods full of omega-3 fatty acids, from the animal and vegetable roots, strengthens the heart’s membranes and helps improve the prognosis in the event of a …
Active way of life related with lower risk of death from a heart failure Kumar Jeetendra | February 13, 2021 An active lifestyle is linked with a lower chance of dying immediately from a heart attack, according to a study published today in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC). Heart disease is the leading cause of death globally and prevention is a major public health priority. …
Hydrogel injection could help fix harm to the heart muscle after heart attack Kumar Jeetendra | February 19, 2021 Researchers at CÚRAM, the SFI Research Centre for Medical Devices based at NUI Galway, and BIOFORGE Lab, at the University of Valladolid in Spain, have developed an injectable hydrogel which might help repair and prevent additional damage to the heart muscle following a heart attack occasion. The results of their research have only been published …
New Stem cell conveying hydrogel could assist the heart with recuperating myocardial ischemia Kumar Jeetendra | August 11, 2021 When blood vessels that feed the heart become blocked, damage to the heart muscle can occur and this can affect cardiac function. By stimulating the formation of new blood vessels, a new stem-cell-carrying gel helps mice overcome this condition called myocardial Infarction. The stem cell delivery system was developed by scientists from Kansai University, Japan. …
Alembic Pharma Gets USFDA Nod for Ticagrelor 60 mg Tablets Kumar Jeetendra | November 1, 2025 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, 60 mg. The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Brilinta Tablets, 60 mg, of AstraZeneca Pharmaceuticals LP (AstraZeneca). Ticagrelor tablets are …
